Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 9;13(1):e0190374.
doi: 10.1371/journal.pone.0190374. eCollection 2018.

Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells

Affiliations

Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells

HyunTae V Hwang et al. PLoS One. .

Abstract

Previously, quercetin has been reported to be a senolytic, a drug that selectively removes senescent cells, in HUVECs. However, we found neither quercetin nor Q3G was effective as a senolytic for adult human endothelial cells.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
A) The experimental timeline. Cells were treated with either quercetin or Q3G for 48 hours before assays. B) A representative SABG staining comparing EP and SEN cells. Many of the SEN cells show characteristic flattened morphology, and are stained blue due to increased SABG activity. C) Representative image of the western blot and densitometry data for Lamin B1. *p<0.05 vs. baseline (N = 3 samples/group, per donor), T-test.
Fig 2
Fig 2
Relative cell abundance following quercetin A) and Q3G B) treatment of EP and SEN from three different donors. Cell proliferation was measured 48 hours after treatment, and was compared against the baseline count of cells frozen just prior to beginning treatment (t0). Values significantly lower than the t0 are indicated by asterisks. *p<0.05 vs. baseline (N = 16 wells/group, per donor), Kruskal-Wallis and Mann-Whitney U tests.
Fig 3
Fig 3
Live-Dead assay for quercetin (A) and Q3G (B) treatment of EP and SEN cells from the same three different donors. Data reflect the percentage of dead cells in response to different concentrations of quercetin or Q3G. N ≥ 6 wells/group, per donor. Approximately 1000 non-fragmented cells were scored for each N. *p<0.05 vs. baseline value. One-way ANOVA was used for Q3G data, which are normally distributed. Kruskal-Wallis and Mann-Whitney U tests were used for quercetin treatment to account for non-normality.
Fig 4
Fig 4. Manual quantification of SABG stain-positive cells.
SEN cells from the same three donors were treated with 6 μM quercetin and 100 μM Q3G followed by SABG staining. Manual counting was done to assess percent of SABG positive cells. *p<0.05 vs. baseline value (N = 12 wells/group, per donor, where each N ranged from 40 to 160 cells). T-test was used to determine statistical significance between control and test groups for each donor.

Similar articles

Cited by

References

    1. D'Andrea G. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia. 2015;106:256–71. 10.1016/j.fitote.2015.09.018. 10.1016/j.fitote.2015.09.018 - DOI - DOI - PubMed
    1. Scambia G, Ranelletti F, Panici PB, Piantelli M, Bonanno G, De Vincenzo R, et al. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. British journal of cancer. 1990;62(6):942 - PMC - PubMed
    1. Wright B, Moraes LA, Kemp CF, Mullen W, Crozier A, Lovegrove JA, et al. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. British journal of pharmacology. 2010;159(6):1312–25. Epub 2010/02/13. 10.1111/j.1476-5381.2009.00632.x ; PubMed Central PMCID: PMCPmc2848935. - DOI - PMC - PubMed
    1. Boesch-Saadatmandi C, Loboda A, Wagner AE, Stachurska A, Jozkowicz A, Dulak J, et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J Nutr Biochem. 2011;22(3):293–9. Epub 2010/06/29. 10.1016/j.jnutbio.2010.02.008 . - DOI - PubMed
    1. Boots AW, Haenen GRMM, Bast A. Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology. 2008;585(2–3):325–37. 10.1016/j.ejphar.2008.03.008. 10.1016/j.ejphar.2008.03.008 - DOI - DOI - PubMed

Publication types